Antiproteinuric effect of KD3-671, an angiotensin II type 1 receptor antagonist, in rats with accelerated passive Heymann nephritis

Japanese Journal of Pharmacology

Volumn 88, Issue 2, 2002, Pages 213-216

  Nagamatsu, Tadashi ^a   Nagao, Toshiyuki ^a   Hayashi, Kazumi ^a   Suzuki, Yoshio ^a  

^a MEIJO UNIVERSITY   (Japan)

Author keywords

Angiotensin type 1 receptor antagonist; Antiproteinuric effect; Heymann nephritis

Indexed keywords

4,5,6,7 TETRAHYDRO 8 OXO 2 PROPYL 1 [[2' (1H TETRAZOL 5 YL)BIPHENYL 4 YL]METHYL]CYCLOHEPTIMIDAZOLE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; NITROGEN; PROTEIN; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL MODEL; HEYMANN NEPHRITIS; INHIBITION KINETICS; MALE; METABOLIC PARAMETERS; NONHUMAN; PROTEINURIA; RAT;

EID: 0036122818     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.88.213     Document Type: Article

References (14)

1. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
2. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
3. The biology of angiotensin II receptors
4. Cellular expression of angiotensin type-1 receptor mRNA in the kidney
5. Angiotensin II type I receptor antagonist suppresses proteinuria and glomerular lesions in experimental nephritis
6. Glomerular disorder
7. Pharmacological properties of KT3-671, a novel nonpeptide angiotensin II receptor antagonist
8. Accelerated passive Heymann nephritis in rats as experimental model for membranous glomerulonephritis and effects of azathioprine and prednisolone on the nephritis
9. The rapid determination of albumin in urine
10. A rapid method for cholesterol determination with a single reagent
11. The antiproteinuric action of angiotensin-converting enzyme is dependent on kinin
12. Antihypertensive effect of chronic KT3-671, a structurally new nonpeptide angiotensin AT1-receptor antagonist, in stroke-prone spontaneously hypertensive rats
13. Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2) 27 rat
14. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies